Cancer Vaccines Market Anticipated to Witness Rapid Growth of 36% CAGR from 2026 to 2036#USA#Las_Vegas#Immunotherapy#Cancer_Vaccines#mRNA_Technology
Cancer Vaccines Market Anticipated to Witness Rapid Growth of 36% CAGR from 2026 to 2036
The cancer vaccines market is set for remarkable growth, driven by increased cancer incidence and innovative therapies. This report explores key developments and forecasts.
third-news.com
September 21, 2026 at 2:38 PM
Cancer Vaccines Market Anticipated to Witness Rapid Growth of 36% CAGR from 2026 to 2036#USA#Las_Vegas#Immunotherapy#Cancer_Vaccines#mRNA_Technology
Moderna Japan Receives Approval for New COVID-19 Vaccine for Ages 12 and Up#Japan#Tokyo#COVID-19_vaccine#mRNA_Technology#Moderna_Japan
Moderna Japan Receives Approval for New COVID-19 Vaccine for Ages 12 and Up
Moderna Japan has received manufacturing and sales approval for its new COVID-19 vaccine, Emnex Spike®, for individuals aged 12 and above, enhancing immunization options.
third-news.com
May 20, 2026 at 3:02 AM
Moderna Japan Receives Approval for New COVID-19 Vaccine for Ages 12 and Up#Japan#Tokyo#COVID-19_vaccine#mRNA_Technology#Moderna_Japan
etherna's mRNA and LNP Platforms Catalyze Dropshot Therapeutics into Clinical Development#Belgium#etherna#Niel#mRNA_Technology#Dropshot_Therapeutics
etherna's mRNA and LNP Platforms Catalyze Dropshot Therapeutics into Clinical Development
etherna's innovative mRNA and LNP platforms enable Dropshot Therapeutics to advance their renal target into the clinical stage, marking a significant milestone in biotechnology.
third-news.com
May 19, 2026 at 12:46 PM
etherna's mRNA and LNP Platforms Catalyze Dropshot Therapeutics into Clinical Development#Belgium#etherna#Niel#mRNA_Technology#Dropshot_Therapeutics
Phylex BioSciences Accelerates Hantavirus Vaccine Development Using AI Technology#USA#Del_Mar#mRNA_Technology#Phylex_BioSciences#Andes_hantavirus
Phylex BioSciences Accelerates Hantavirus Vaccine Development Using AI Technology
Phylex BioSciences swiftly develops an AI-derived mRNA nanoparticle vaccine targeting the Andes hantavirus, demonstrating rapid response capabilities.
third-news.com
May 13, 2026 at 7:52 PM
Phylex BioSciences Accelerates Hantavirus Vaccine Development Using AI Technology#USA#Del_Mar#mRNA_Technology#Phylex_BioSciences#Andes_hantavirus
New Nanoparticle-Based Vaccines Show Promise in Allergy Treatment and Prevention#United_States#Cincinnati#Allergy_Treatment#Nanoparticle_Vaccine#mRNA_Technology
New Nanoparticle-Based Vaccines Show Promise in Allergy Treatment and Prevention
A groundbreaking lipid nanoparticle vaccine shows promise in managing severe allergies, offering new hope against the global allergy epidemic.
third-news.com
September 23, 2025 at 4:38 PM
New Nanoparticle-Based Vaccines Show Promise in Allergy Treatment and Prevention#United_States#Cincinnati#Allergy_Treatment#Nanoparticle_Vaccine#mRNA_Technology